ArticleAPL bioengineering2025

Formononetin suppresses osteosarcoma by targeting MYO1B and remodeling the tumor immune microenvironment.

Yun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.